ClinicalTrials.Veeva

Menu

Coronary Artery Disease (CAD) in Patients HIV-infected (CoroVIH)

H

Hôpital Européen Marseille

Status

Unknown

Conditions

HIV Infections

Treatments

Other: coronary computed tomographic angiographic (CCTA)

Study type

Observational

Funder types

Other

Identifiers

NCT04579146
2019-A00219-48

Details and patient eligibility

About

HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a substantial proportion of obstructive CAD. Degree of stenosis is associated with immunoactivation (lymphocyte and monocyte) and microbial translocation

Enrollment

60 estimated patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

HIV-infected patients >= 45 years with 2 or more CV risk factors currently on ART HIV-RNA < 50 copies >= 12 months (one blip allowed) Asymptomatic regarding cardiac symptoms (chest pain, syncope, dyspnea) Stable ART for more than 6 months

Exclusion criteria

  • Sign of coronary pathology (chest pain, syncope, dyspnea).
  • ATCD of allergy to IV contrast agents
  • Chronic inflammatory disease other than HIV
  • Subject to a measure for the protection of justice

Trial design

60 participants in 1 patient group

HIV-1 patients and treated effectively for more than 12 months
Description:
X-ray examination with contrast by a 64-slice CT coronary angiography.
Treatment:
Other: coronary computed tomographic angiographic (CCTA)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems